title: Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth.
abstract: Melanocytes (MCs) are melanin-producing cells of the skin that are derived from neural crest cells. Vitiligo vulgaris is a common depigmentation disorder resulting from the destruction of functional MCs in the affected skin. The three prevailing pathomechanisms of vitiligo are the immune hypothesis, the neural hypothesis and the autocytotoxic hypothesis. None of these mechanisms has been conclusively proven. Melanoblasts (MBs) in the outer root sheath of the hair follicles are the reservoir cells for repigmentation. Recovery from vitiligo is initiated by activation and proliferation of these MBs, followed by upward migration to the nearby epidermis that forms perifollicular pigmentation islands. Migration, proliferation and differentiation of MCs and MBs are regulated by keratinocyte-derived factors and some coat color genes. Any therapy for vitiligo must explain not only the repopulation of MCs but also their functional development. In patients with vitiligo, MCs are destroyed in the skin, the eyes, and possibly the ears. However, the concept of vitiligo as a systemic disease will be clearly established only when the mechanisms involved in vitiligo are identified. Recent advances in the fields of neural crest cell culture and molecular genetics have opened new perspectives in the understanding of vitiligo. Not only will this result in better treatments for vitiligo patients, but possibly will also provide a key to triggering nerve cell regrowth in other nervous diseases.
authors.affiliation: Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC. dermyu@kmu.edu.tw
authors.forename: H-S
authors.initials: HS
authors.lastname: Yu
mesh_terms: D000818:Animals; D006801:Humans; D008544:Melanocytes / Q000473:pathology*; D008954:Models, Biological; D009420:Nervous System / Q000166:cytology / Q000196:embryology; D010858:Pigmentation / Q000502:physiology*; D014820:Vitiligo / Q000209:etiology / Q000473:pathology* / Q000628:therapy